---
figid: PMC6089851__gr3
figlink: /pmc/articles/PMC6089851/figure/f0015/
number: F3
caption: Activation and feedback regulation of the MAPK pathway. The classical MAPK
  pathway is activated in human tumors by upstream receptor tyrosine kinases (RTK)
  or by mutations in RAS, BRAF, and MEK1. RTKs activate RAS by recruiting adaptor
  proteins (e.g., GRB-2) and exchange factors (e.g., SOS). RAS activation promotes
  the formation of RAF dimers, which activate MEK-ERK cascade through phosphorylation.
  ERK pathway activity is regulated by negative feedback at multiple levels, including
  the transcriptional activation of DUSP proteins that negatively regulate the pathway.
  ERK also phosphorylates and thus regulates CRAF and MEK activity directly. ERK,
  or its immediate substrate RSK, also phosphorylates SOS at several residues, inhibiting
  its activity and thus negatively regulating RAS activity.
pmcid: PMC6089851
papertitle: Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy.
reftext: Feifei Liu, et al. Acta Pharm Sin B. 2018 Jul;8(4):552-562.
pmc_ranked_result_index: '71687'
pathway_score: 0.9469281
filename: gr3.jpg
figtitle: Activation and feedback regulation of the MAPK pathway
year: '2018'
organisms: Homo sapiens
ndex: ce636493-def7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6089851__gr3.html
  '@type': Dataset
  description: Activation and feedback regulation of the MAPK pathway. The classical
    MAPK pathway is activated in human tumors by upstream receptor tyrosine kinases
    (RTK) or by mutations in RAS, BRAF, and MEK1. RTKs activate RAS by recruiting
    adaptor proteins (e.g., GRB-2) and exchange factors (e.g., SOS). RAS activation
    promotes the formation of RAF dimers, which activate MEK-ERK cascade through phosphorylation.
    ERK pathway activity is regulated by negative feedback at multiple levels, including
    the transcriptional activation of DUSP proteins that negatively regulate the pathway.
    ERK also phosphorylates and thus regulates CRAF and MEK activity directly. ERK,
    or its immediate substrate RSK, also phosphorylates SOS at several residues, inhibiting
    its activity and thus negatively regulating RAS activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUND
  - FOSL1
  - DUSP1
  - DUSP5
  - CCND1
  - JUNB
  - CXCL8
  - MCL1
  - CDKN1A
  - BCL2
  - TGFB1
  - TGFB2
  - ASS1
  - JUN
  - RPS6KA6
  - RPS6KA1
  - RPS6KA2
  - MAP2K1
  - MAP2K2
  - NUCB1
  - BRAF
  - DUSP6
  - FOSL2
  - SOS1
  - SOS2
  - SRC
  - FYN
  - TGFA
  - TGFB3
  - RPS6KB1
  - ETS2
  - ETS1
  - MAPK3
  - MAPK1
  - FOSB
  - FOS
  - GRB2
  - HBEGF
  - HRAS
  - KRAS
  - RAF1
  - RPS6KA3
  - RPS6KA5
  - RPS6KB2
  - NRAS
  - ARAF
  - RPS6KA4
  - Ser
  - Thr
  - Ser217
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: DUSP1,DUSP5,DUSP6
  symbol: DUSP1
  source: hgnc_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: DUSP5
  symbol: DUSP5
  source: hgnc_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: CCND1,P21CIP1,P16INKA
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: MCL1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: CCND1,P21CIP1,P16INKA
  symbol: p21CIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: BCL2,
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: a√ü
  symbol: ASS
  source: hgnc_prev_symbol
  hgnc_symbol: ASS1
  entrez: '445'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Nuc
  symbol: NUC
  source: hgnc_alias_symbol
  hgnc_symbol: NUCB1
  entrez: '4924'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: DUSP6
  symbol: DUSP6
  source: hgnc_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: SRC/FYN
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: SRC/FYN
  symbol: FYN
  source: hgnc_symbol
  hgnc_symbol: FYN
  entrez: '2534'
- word: TGF-a,
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: TranscriptionAP-1,ETS,etc.
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: TranscriptionAP-1,ETS,etc.
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: FOS
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: GRB-2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: HB-EGF,
  symbol: HBEGF
  source: hgnc_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
chemicals:
- word: Ser
  source: MESH
  identifier: C530429
- word: Thr
  source: MESH
  identifier: C055175
- word: Ser217
  source: MESH
  identifier: C530429
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6089851__F3
redirect_from: /figures/PMC6089851__F3
figtype: Figure
---
